Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with lung cancer: results from an interim analysis of the non-interventional study NADIR. 7. Juni 2016 Potthoff, K., Lück, A., Frost, N., Losem, C., Weide, R., Schulz, H., 2016. Oncol Res Treat 39 (suppl3)(P949), 292. doi:10.1159/000449050 Abstract Patient-reported outcomes of 905 patients with breast cancer two years after start of curative systemic treatment. Marschner, N., Trarbach, T., Dörfel, S., Meyer, D., Müller-Hagen, S., Zaiss, M., Boller, E., Kruggel, L., 2016. Oncol Res Treat 39 (suppl 5)(V385), 116. doi:10.1159/000449050… Weiterlesen Time to deterioration as measure for symptom burden and quality of life – Data from the LuLife project in 507 patients with non-small cell lung cancer in Germany. von Verschuer, U., Sandner, R., Tessen, H.-W., Emde, T.-O., Schnitzler, M., Binninger, A., Jänicke, M., Marschner, N., 2016. Oncol Res Treat 39 (suppl 3)(V986), 303. Weiterlesen